相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EGFR and anti-EGFR nanobodies: review and update
Jafar Sharifi et al.
JOURNAL OF DRUG TARGETING (2021)
Immunotoxins and nanobody-based immunotoxins: review and update
Mohammad Reza Khirehgesh et al.
JOURNAL OF DRUG TARGETING (2021)
Development of a Recombinant Monospecific Anti-PLGF Bivalent Nanobody and Evaluation of it in Angiogenesis Modulation
Abolfazl Nikooharf et al.
MOLECULAR BIOTECHNOLOGY (2020)
A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis
Elmira Karami et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Preparation and characterization of humanized nanobodies targeting the dimer interface of epidermal growth factor receptor (EGFR)
He Zhu et al.
PROTEIN EXPRESSION AND PURIFICATION (2019)
Purification of a Novel Anti-VEGFR2 Single Chain Antibody Fragment and Evaluation of Binding Affinity by Surface Plasmon Resonance
Shirafkan Kordi et al.
ADVANCED PHARMACEUTICAL BULLETIN (2019)
Single domain based bispecific antibody, Muc1-Bi-1, and its humanized form, Muc1-Bi-2, induce potent cancer cell killing in muc1 positive tumor cells
Yumei Li et al.
PLOS ONE (2018)
Transglutaminase mediated PEGylation of nanobodies for targeted nano-drug delivery
Tiantian Wu et al.
JOURNAL OF MATERIALS CHEMISTRY B (2018)
Blocking EGFR Activation with Anti-EGF Nanobodies via Two Distinct Molecular Recognition Mechanisms
Salvador Guardiola et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
A camelid nanobody against EGFR was easily obtained through refolding of inclusion body expressed in Escherichia coli
Li Xu et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2017)
Shape-dependent enzyme-like activity of Co3O4 nanoparticles and their conjugation with his-tagged EGFR single-domain antibody
Wei Zhang et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A
Bahman Akbari et al.
ANTI-CANCER DRUGS (2017)
Nanobodies as therapeutics: big opportunities for small antibodies
Sophie Steeland et al.
DRUG DISCOVERY TODAY (2016)
Recent progress in protein-protein interaction study for EGFR-targeted therapeutics
Rebecca Christine Feiner et al.
EXPERT REVIEW OF PROTEOMICS (2016)
Development and evaluation of a single domain antibody against human epidermal growth factor receptor (EGFR)
Shiva Ahdi Khosroshahi et al.
PROTEIN EXPRESSION AND PURIFICATION (2016)
Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR)
Bahman Akbari et al.
PROTEIN EXPRESSION AND PURIFICATION (2016)
Structural Characterization of Humanized Nanobodies with Neutralizing Activity against the Bordetella pertussis CyaA-Hemolysin: Implications for a Potential Epitope of Toxin-Protective Antigen
Aijaz Ahmad Malik et al.
TOXINS (2016)
Humanized-VHH Transbodies that Inhibit HCV Protease and Replication
Surasak Jittavisutthikul et al.
VIRUSES-BASEL (2015)
Nanobody-photosensitizer conjugates for targeted photodynamic therapy
Raimond Heukers et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Diagnostic nanoparticle targeting of the EGF-receptor in complex biological conditions using single-domain antibodies
K. Zarschler et al.
NANOSCALE (2014)
Nanobodies and Nanocrystals: Highly Sensitive Quantum Dot-Based Homogeneous FRET Immunoassay for Serum-Based EGFR Detection
K. David Wegner et al.
SMALL (2014)
Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells
Isil Altintas et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Inhibition of Tumor Growth by Targeted Anti-EGFR/IGF-1R Nanobullets Depends on Efficient Blocking of Cell Survival Pathways
Roy van der Meel et al.
MOLECULAR PHARMACEUTICS (2013)
High-yield production of functional soluble single-domain antibodies in the cytoplasm of Escherichia coli
Kristof Zarschler et al.
MICROBIAL CELL FACTORIES (2013)
Pentavalent Single-Domain Antibodies Reduce Campylobacter jejuni Motility and Colonization in Chickens
Ali Riazi et al.
PLOS ONE (2013)
Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains
Karl R. Schmitz et al.
STRUCTURE (2013)
scFv Antibody: Principles and Clinical Application
Zuhaida Asra Ahmad et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth
Rob C. Roovers et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Correlation Between Epidermal Growth Factor Receptor-Specific Nanobody Uptake and Tumor Burden: A Tool for Noninvasive Monitoring of Tumor Response to Therapy
Lea Olive Tchouate Gainkam et al.
MOLECULAR IMAGING AND BIOLOGY (2011)
Kinetic analysis of novel mono- and multivalent VHH-fragments and their application for molecular imaging of brain tumours
U. Iqbal et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Differential tumor-targeting abilities of three single-domain antibody formats
Andrea Bell et al.
CANCER LETTERS (2010)
Downregulation of EGFR by a novel multivalent nanobody-liposome platform
Sabrina Oliveira et al.
JOURNAL OF CONTROLLED RELEASE (2010)
In Vitro Analysis and In Vivo Tumor Targeting of a Humanized, Grafted Nanobody in Mice Using Pinhole SPECT/Micro-CT
Ilse Vaneycken et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
Cecile Vincke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT
Lea Olive Tchouate Gainkam et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Analyzing the Degree of humanness of antibody sequences
K. R. Abhinandan et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies
Rob C. Roovers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies
E De Genst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Construction and high-level expression of a single-chain Fv antibody fragment specific for acidic isoferritin in Escherichia coli
JQ Guo et al.
JOURNAL OF BIOTECHNOLOGY (2003)
分享论文
